People

Elizabeth Fair, PhD, MPH

Co-Director, UCSF Center for Tuberculosis
Co-Director, UC TRAC Developmental Core
Professor
Medicine

My research is focused on tuberculosis (TB), TB/HIV, global health, and implementation research. Active projects include evaluating the feasibility, yield, and cost-effectiveness of TB contact investigation in Tanzania; exploring TB-associated stigma in Bangladesh; evaluating innovative technologies for TB education and control in Madagascar; and implementing active TB case finding strategies in Mozambique. I serve as a regular consultant for the American Thoracic Society (ATS), World Health Organization (WHO), and the Dutch Tuberculosis Group (KNCV).

Jennifer Flood, MD, MPH

Affiliate
Epidemiology & Biostatistics

Dr. Jennifer Flood is the Chief of the Tuberculosis Control Branch at the California Department of Public Health. She is an infectious disease physician and UCSF Clinical Professor of Medicine and has provided clinical care for patients with TB infection at the San Francisco Department of Public Health TB Clinic for over two decades. In her capacity as state TB controller, Dr. Flood has led the development of a TB elimination plan for California and established the California multidrug-resistant TB (MDR-TB) service.

Monica Gandhi, MD, MPH

Professor of Clinical Medicine
Medicine

My current research program is focused on identifying low-cost solutions to measuring antiretroviral levels in resource-poor settings, such as determining drug levels in hair samples, including levels of anti-tuberculosis drugs. I also participate in research efforts on HIV prevention in women.  I have an interest at UCSF in HIV education and mentorship. I co-directed the "Communicable Diseases of Global Health Importance" course in the Global Health Sciences Masters program from 2008-2015, and served as the overall Education Director of the HIV, ID and Global Medicine Division.

Eric Goosby, MD

Professor of Clinical Medicine
Medicine

Dr Eric Goosby was appointed the UN Secretary-General’s Special Envoy on Tuberculosis, 2015-2018.  As Special Envoy, Dr Goosby worked to raise the profile of the fight against TB and promote the adoption, financing and implementation of the World Health Organization’s global End TB strategy and its international targets for TB prevention, care and control, and focused on establishing the first-ever UN High Level Meeting on TB in 2019.  Dr Goosby has dedicated his professional life to tackling global health diseases, particularly HIV/AIDS and TB.

Judith Hahn, PhD, MA

Professor In Residence
Medicine

My research interests lie in the epidemiology at the intersection of substance use and infectious diseases. My research team is currently conducting a NIH-funded R01 study to examine changes in alcohol consumption in the course of HIV care in Uganda. We are using novel biomarkers of alcohol consumption to gain objective measurements of alcohol consumption, as well as in-depth interviews to examine reasons for changes in alcohol consumption.

Diane Havlir, MD

Professor of Medicine
Medicine

Diane Havlir, MD is a UCSF Professor and Chief of the HIV, Infectious Diseases and Global Medicine Division at ZSFG, home to world-renowned HIV research and Ward 86 clinical program. She is also the Associate Chair of Clinical Research in the Department of Medicine, Principal Investigator of the Sustainable East Africa Research in Community Health (SEARCH) Collaboration, Director of the UCSF AIDS Research Institute (ARI), and serves as Robert L. Weiss Memorial Chair for HIV/AIDS Research. She was elected to the National Academy of Medicine in 2019.

Nancy Hills, PhD

Adjunct Professor
Neurology

Philip Hopewell, MD

Professor of Medicine Emeritus
Medicine

 I began my career as a consultant in TB control to the Nigerian government in the war-affected areas of eastern Nigeria. Later, my interest in TB control in developing countries was fostered by my work in the Pan-American Health Organization in 1980-1981 and with the Stop TB Partnership, based at the World Health Organization in Geneva in 2003. I have been on the faculty at UCSF, based at San Francisco General, since 1973, where I served as Chief of the Division of Pulmonary and Critical Care Medicine from 1989 to 1998 and Associate Dean 1998 to 2004.

Laurence Huang, MD

Professor of Clinical Medicine
Medicine

My research focus is on pulmonary diseases affecting persons with HIV. Currently, I am PI/Co-PI on 3 main studies, 1) IHOP: The International HIV-associated Opportunistic Pneumonias (IHOP) Study is a multi-national cohort study whose goal is to improve our understanding of the epidemiology, etiology, and outcome of pneumonias in persons with HIV infection. 2) Lung MicroChip: The Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroChip) Study is a multi-cohort study whose goal is to examine the composition and function of the lung microbiome in persons with HIV.

Peter Hunt

Professor In Residence
Medicine

My primary research focus is on the inflammatory consequences of HIV infection. Our clinic-based translational research program seeks to understand the determinants of persistent immune activation both in the presence and the absence of antiretroviral therapy, and to assess the impact of immune activation on clinical outcomes.

Devan Jaganath, MD, MPH

UCSF Center for Tuberculosis Pediatric TB Chair
Assistant Professor
Pediatrics

My research is focused on diagnostics, biomarker discovery, data science and digital health to improve TB care, with a particular interest in childhood TB. I am part of the END Childhood TB Study in Kampala, Uganda to evaluate novel non-sputum, biomarker-based tests for pediatric intra-thoracic TB. In biomarker discovery, I am working to identify a urine-based proteomic biosignature for diagnosing childhood TB, and I am part of the COMBO study to examine other novel pathogen and host biomarkers for TB diagnosis in children.

Babak Javid, MB, PhD

Co-Director, UCSF Center for Tuberculosis
Co-Director, UC TRAC Basic Science Core
Professor
Medicine

Dr. Javid is a physician-scientist, Wellcome Trust Investigator and Associate Professor in the Division of Experimental Medicine at UCSF.  His research focuses on fundamental mycobacterial pathophysiology, regulation of adaptive protein synthesis, molecular mechanisms of antibiotic tolerance and human humoral immunity to tuberculosis.  He went to medical school at the University of Cambridge, and after residency in general (internal) medicine returned to Cambridge to study for a PhD in immunobiology as an MRC training fellow. Following fellowship in infectious diseases, Dr.

Pages